Skip to main content

Surface Plasmon Resonance Investigations of Human Epidermal Growth Factor Receptor 2

Buy Article:

$29.00 plus tax (Refund Policy)

Abstract:

This investigation utilizes surface plasmon resonance (SPR) spectroscopy to detect and quantify human epidermal growth factor receptor 2 (HER-2), an oncogene product that is over-expressed in some aggressive forms of breast cancer. Specifically, the HER-2 trans-membrane protein p185 and its extra cellular fragment p105 are analytes targeted in this work by using a gold-based biosensor slide on which an anti-HER-2 antibody has been immobilized by attachment to Protein G that is fixed to the gold film. A detection limit of ≥11 ng/mL for p185 resulted when trastuzumab was used as the anti-HER-2 antibody on the biosensor slide. Experiments with semi-purified p105 revealed that it binds weakly and reversibly to trastuzumab, therefore complicating its detection and quantification. Results of studies that reacted a 13-amino-acid peptide (PP13) from the HER-2 kinase domain with its specific antibody were critically different than p185 and p105 studies. Spectral analysis of the reflectivity at constant bulk buffer refractive index revealed a progressive negative SPR shift over time. A negative shift suggests that a loss of protein mass from the anti-PP13 antibody–Protein G biosensor is occurring. Several possibilities that may explain these negative SPR shifts are discussed.

Keywords: HER-2; HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR-2; PROTEIN G BASED BIOSENSOR SLIDE; SPECTROSCOPY; SPR; SURFACE PLASMON RESONANCE

Document Type: Research Article

DOI: http://dx.doi.org/10.1366/000370206778397498

Affiliations: 1: Department of Chemistry, University of Wyoming, Laramie, Wyoming 82071 2: School of Pharmacy, University of Wyoming, Laramie, Wyoming 82071

Publication date: September 1, 2006

More about this publication?
sas/sas/2006/00000060/00000009/art00013
dcterms_title,dcterms_description,pub_keyword
6
5
20
40
5

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more